| Approach to a child with joint pain (DNB 2017/2)6 | 194 | 2017 |
| Classification and features of JRA (DNB 1996/2)14 | 196 | 1996 |
| What are the clinical manifestations of juvenile rheumatoid arthritis? Discuss the differential diagnosis and management (DNB 2004/2)3+3+4 | 196 | 2004 |
| Write the current classification used in JRA. Outline the management plan for JRA (DNB 2006/1)10 | 196 | 2006 |
| Tabulate differentiating features of various types of juvenile Rheumatoid arthritis (DNB 2008/1)10 | 196 | 2008 |
| Tabulate the classification of Juvenile Idiopathic arthritis and state principles of its treatment (DNB 2010/2)4+6 | 196 | 2010 |
| A seven-year-old girl is admitted with pain and swelling of right knee and left ankle joint of two weeks' duration. Enumerate the likely causes. Discuss the differential diagnosis highlighting important pointers in history, examination and investigations (DNB 2011/1)4+6 | 196 | 2011 |
| Tabulate the differentiating features of various types of JRA. Outline a scheme of investigation for a child with suspected JRA (DNB 2011/1)3+4+3 | 196 | 2011 |
| Outline the diagnostic criteria of juvenile rheumatoid arthritis (DNB 2012/1)5 | 196 | 2012 |
| Tabulate the differentiating clinical features and the diagnostic approach of Juvenile Idiopathic Arthritis (JIA). Outline the principles of management of polyarticular JIA (DNB 2012/1) 4+3+3 | 196 | 2012 |
| Define Juvenile Idiopathic Arthritis (JIA). Outline the classification of JIA. Discuss the mimickers of rheumatic diseases in children (DNB 2013/1)2+4+4 | 196 | 2013 |
| A six-year-old boy presents with painful swelling of his right knee. Enumerate the likely causes. Define Juvenile Idiopathic arthritis and discuss its management (DNB 2014/1)2+2+6 | 196 | 2014 |
| A) Disease modifying agents used for JIA B) Biological anti-TNF agents for JIA (DNB 2014/2) 5+5 | 196 | 2014 |
| a) ILAR classification of juvenile idiopathic arthritis b) Clinical features of systemic onset disease and give the differential diagnosis (DNB 2015/1)4+4+2 | 196 | 2015 |
| Treatment of Juvenile idiopathic arthritis (DNB 2018/1)5 | 196 | 2018 |
| Systemic onset JIA (DNB 2019/2)6 | 196 | 2019 |
| Juvenile rheumatoid arthritis in children - Classification and Diagnosis (DNB 2021/2)5 | 196 | 2021 |
| Classification and diagnostic criteria of JIA (DNB 2023/1)5 | 196 | 2023 |
| Differential diagnosis in a child with swelling of multiple joints for 6 weeks duration (DNB 2023/1)5 | 196 | 2023 |
| Biologic therapies in Juvenile Idiopathic Arthritis (DNB 2023/2)5 | 196 | 2023 |
| Write briefly on systemic onset juvenile idiopathic arthritis (DNB 2024/2)4 | 196 | 2024 |
| Juvenile idiopathic arthritis: a) Clinical features b) Investigation c) Treatment (DCH 2024/2)3+3+4 | 196 | 2024 |
| How do you classify and treat lupus nephritis (DNB 2016/1)5 | 199 | 2016 |
| Cutaneous manifestations of lupus erythematosus (DNB 2018/1)5 | 199 | 2018 |
| SLE-Diagnostic criteria (DNB 2018/2)5 | 199 | 2018 |
| Diagnosis of systemic lupus erythematosus (DNB 2023/2)5 | 199 | 2023 |
| Criteria for diagnosis of Systemic Lupus Erythematosus (SLE) (DNB 2024/1)5 | 199 | 2024 |
| Paediatric SLE: a) Clinical manifestation b) Investigation c) Diagnostic criteria d) Treatment (DCH 2024/2)3+3+4 | 199 | 2024 |
| Clinical features of juvenile dermatomyositis (DNB 2018/2)5 | 200 | 2018 |
| Diagnosis and management of Juvenile Dermatomyositis (DNB 2023/2)5 | 200 | 2023 |
| Macrophage activation syndrome (DNB 2016/01)5 | 207 | 2016 |
| Macrophage activation syndrome (DNB 2019/2)4 | 207 | 2019 |
| Macrophage activation syndrome (DNB 2022/2)5 | 207 | 2022 |
| Macrophage activation syndrome (DNB 2024/2)5 | 207 | 2024 |
| Kawasaki Syndrome (DNB 2000/1)15 | 208 | 2000 |
| Phases and complications of Kawasaki's disease (DNB 2006/1)10 | 208 | 2006 |
| Discuss the presentation, diagnostic criteria for Kawasaki Disease. What is the management strategy? What are the complications? (DNB 2008/1)10 | 208 | 2008 |
| Discuss the pathogenesis, differential diagnosis and echocardiography findings in Kawasaki Disease (KD). How is the classical KD different from Atypical KD? (DNB 2009/1)6+4 | 208 | 2009 |
| Describe clinical manifestations of classical and atypical Kawasaki disease. Provide algorithmic approach to a suspected case of Kawasaki disease. Enumerate various treatment modalities (DNB 2011/1)4+4+2 | 208 | 2011 |
| Write short notes on: Diagnostic criteria for Kawasaki Disease (DNB 2013/2)5 | 208 | 2013 |
| Algorithmic approach to a suspected case of Kawasaki disease. Enumerate its complications and outline the management (DNB 2015/2)5+2+3 | 208 | 2015 |
| Treatment of Kawasaki disease (DNB 2017/2)5 | 208 | 2017 |
| Diagnosis and management of Kawasaki disease [DNB 2018/2]5 | 208 | 2018 |
| Therapy and follow-up of Kawasaki disease (DNB 2019/1)5 | 208 | 2019 |
| Role of salicylates in Kawasaki disease (DNB 2020/1)5 | 208 | 2020 |
| Management of a child with Kawasaki disease (DNB 2020/2)5 | 208 | 2020 |
| Kawasaki Disease - Classification of coronary involvement and management (DNB 2021/2)4 | 208 | 2021 |
| Tabulate the differences in clinical and laboratory features of Kawasaki disease and MIS-C (DNB 2022/2)5 | 208 | 2022 |
| Kawasaki disease features (DCH 2023/2)5 | 208 | 2023 |
| Kawasaki disease management (DCH 2023/2)5 | 208 | 2023 |
| Discuss Briefly clinical presentation and management of HSP (DNB 2007/1)10 | 210 | 2007 |
| Classify vasculitis based on size of involved vessels and give examples of each category. Describe etiology, clinical features and management of Takayasu's arteritis (DNB 2009/2)5+5 | 210 | 2009 |
| Describe the diagnostic approach and management of a six-year-old child presenting with purpuric rash and pedal edema following an episode of acute diarrhea (DNB 2011/2)4+6 | 210 | 2011 |
| HSP clinical features and diagnosis (DNB 2018/2)5 | 210 | 2018 |
| Diagnosis and treatment of HSP (DNB 2019/1)5 | 210 | 2019 |
| Clinical presentation & management of Henoch-Schonlein purpura (DNB 2020/2)5 | 210 | 2020 |
| Systemic onset juvenile idiopathic arthritis (DNB 2024/2)5 | 196 | 2024 |
| Macrophage activation syndrome (DNB 2024/2)5 | 207 | 2024 |
| Diagnostic criteria of Kawasaki disease and its management in children (DNB 2025/1)5 | 208 | 2025 |